In PC experimental studies, c-MYC expression and/or the combined deletion of PTEN/SMAD4 or PTEN/TP53 expanded immunosuppressive tumor-associated macrophages and myeloid-derived suppressor cells, promoting tumor immunotolerance and vascularization [132]. This evidence concerns the gene TP53 and neoplasm.